logo-loader

Vector Therapeutics using technology to try and prevent acute Leukemia relapse

Published: 10:10 09 Jan 2019 EST

Vector Therapeutics Corp CEO Daniel Teper  updates Proactive Investor's Christine Corrado at the 11th Annual Biotech Showcase in San Francisco. The New York based pharma company is focused on providing life-changing, precision-immunotherapy treatments for a variety of cancers, mainly leukemia.

Coniagas Battery Metals secures new key ground with focus on...

Coniagas Battery Metals (TSX-V:COS) CEO Frank Basa joined Steve Darling from Proactive to announce the company's strategic acquisition of key ground near SOQUEM’s Cardinal Property, located 80 km southeast of Chibougamau, Quebec. This acquisition underscores Coniagas’ commitment to capitalizing...

36 minutes ago